Khandalavala Karl R, Lohse Christine M, Tombers Nicole M, Link Michael J, Carlson Matthew L
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic.
Department of Quantitative Health Sciences, Mayo Clinic.
Otol Neurotol. 2025 Jun 1;46(5):581-586. doi: 10.1097/MAO.0000000000004495. Epub 2025 Mar 20.
To compare differences in sporadic vestibular schwannoma (VS)-associated patient-reported symptom scores among patients receiving observation, microsurgery, or radiosurgery.
Prospective longitudinal survey.
Tertiary referral center and the national Acoustic Neuroma Association.
Adults with sporadic VS.
Observation, microsurgery, or radiosurgery.
Baseline and follow-up surveys on patient-reported severity of tinnitus, dizziness/imbalance, and headaches scored on a 10-point numeric scale, with higher scores indicating more severe symptoms; changes of 2 or more points from baseline were considered clinically important.
A total of 455 patients were eligible for study with a mean (SD) follow-up of 4.5 (2.4) years, including 122 (27%) managed with observation, 226 (50%) undergoing microsurgery, and 107 (23%) undergoing radiosurgery. Changes in tinnitus severity scores differed significantly among management groups ( p = 0.006), with severity scores increasing significantly in the radiosurgery (+0.8, p = 0.005) group but not in the observation (+0.2, p = 0.5) or microsurgery (-0.2, p = 0.18) groups. The changes in dizziness/imbalance and headache severity scores did not differ significantly among management groups. When comparing clinically important improvements (decrease of 2 or more points), the microsurgery and observation cohorts had a greater proportion of patients experiencing a clinically important improvement in tinnitus compared with the radiosurgery cohort; no other clinically important changes were significantly different among management groups.
In this prospective study of 455 patients comparing patient-reported symptoms after VS management, radiosurgery was associated with worsening tinnitus severity scores overall and resulted in fewer patients reporting clinically important improvements in tinnitus compared with observation and microsurgery. As there was substantial variability in the effect of management modality on changes in symptom severity scores, possible treatment effects on subjective symptoms, including tinnitus, dizziness/imbalance, and headache, should not be used in isolation to inform clinical decision-making for management of sporadic VS.
比较接受观察、显微手术或放射外科治疗的散发性前庭神经鞘瘤(VS)患者报告的症状评分差异。
前瞻性纵向调查。
三级转诊中心和全国听神经瘤协会。
散发性VS成年患者。
观察、显微手术或放射外科治疗。
对患者报告的耳鸣、头晕/失衡和头痛严重程度进行基线和随访调查,采用10分数字评分法,分数越高表明症状越严重;与基线相比变化2分或更多分被认为具有临床意义。
共有455例患者符合研究条件,平均(标准差)随访4.5(2.4)年,其中122例(27%)接受观察治疗,226例(50%)接受显微手术,107例(23%)接受放射外科治疗。耳鸣严重程度评分变化在各治疗组间差异有统计学意义(p = 0.006),放射外科治疗组(+0.8,p = 0.005)的严重程度评分显著增加,而观察治疗组(+0.2,p = 0.5)和显微手术治疗组(-0.2,p = 0.18)则未增加。头晕/失衡和头痛严重程度评分变化在各治疗组间差异无统计学意义。在比较具有临床意义的改善(降低2分或更多分)时,与放射外科治疗组相比,显微手术和观察治疗队列中耳鸣症状有临床意义改善的患者比例更高;各治疗组间其他具有临床意义的变化无显著差异。
在这项对455例患者进行的前瞻性研究中,比较VS治疗后患者报告的症状,放射外科治疗总体上与耳鸣严重程度评分恶化相关,与观察和显微手术相比,报告耳鸣有临床意义改善的患者更少。由于治疗方式对症状严重程度评分变化的影响存在很大差异,因此,对于散发性VS的治疗决策,不应孤立地依据其对包括耳鸣、头晕/失衡和头痛在内的主观症状的可能治疗效果来做出。